Table 1.

Differences in prostate inflammation and prostate cancer according to COVID-19 infections after prostate biopsy.

		Overall	No COVID	COVID+	p value
Results after prostate biopsy
Age (Years)		69 (62–73)	69 (63–72)	68 (60–73)	1
PSA at biopsy (ng/ml)		6.1 (4.5–9.1)	6.1 (4.4–7.7)	7 (4.6–10.4)	0.5
Prostate volume (ml)		50 (19–163)	50 (19–163)	46 (23–116)	0.3
PSA density (ng/ml/cc)		0.09 (0.05–0.36)	0.10 (0.06–0.18)	0.09 (0.05–0.36)	0.7
Irani score (G) n (%)	0	2 (10)	1 (10)	1 (10)	0.1
	1	8 (40)	6 (60)	2 (20)
	2	10 (50)	3 (30)	7 (70)
Irani score (A) n (%)	0	7 (35)	4 (40)	3 (30)	0.3
	1	10 (50)	4 (40)	6 (60)
	2	2 (10)	2 (20)	0 (0)
	3	1 (5)	0 (0)	1 (10)
Irani score (G + A) n (%)	0	2 (10)	1 (10)	1 (10)	0.5
	1	2 (10)	1 (10)	1 (10)
	2	7 (35)	5 (50)	2 (20)
	3	8 (40)	3 (30)	5 (50)
	4	0 (0)	0 (0)	0 (0)
	5	1 (5)	0 (0)	1 (10)
Inflammatory cell infiltration n (%)	Lympho mononuclear infiltration	20 (100)	10 (100)	10 (100)
Results after prostatectomy
Post-operative PSA (ng/ml)		0.02 (0.01–0.02)	0.02 (0.01–0.02)	0.02 (0.01–0.02)	0.1
Gleason Score at Radical Prostatectomy (n, %)	3 + 3	6 (30%)	3 (30%)	3 (30%)	1
	3 + 4	14 (70%)	7 (70%)	7 (70%)
Inflammatory cell infiltration n (%)	Lympho mononuclear infiltration	18 (90)	9 (90)	9 (90)	0.4
	Granulomatous inflammation	1 (5)	1 (10)	0 (0)
	Lympho mononuclear infiltration and granulomatous inflammation	1 (5)	0 (0)	1 (10)
Irani score prostate (G) n (%)	0	2 (10)	1 (10)	1 (10)	0.2
	1	8 (40)	6 (60)	2 (20)
	2	10 (50)	3 (30)	7 (70)
Irani score prostate (A) n (%)	0	7 (35)	4 (40)	3 (30)	0.3
	1	10 (50)	4 (40)	6 (60)
	2	2 (10)	2 (20)	0 (0)
	3	1 (5)	0 (0)	1 (10)
Irani score prostate (G + A) n (%)	0	0 (0)	0 (0)	0 (0)	0.5
	1	0 (0)	0 (0)	0 (0)
	2	1 (5)	1 (10)	0 (0)
	3	4 (20)	2 (20)	2 (20)
	4	10 (50)	4 (40)	6 (60)
	5	4 (20)	3 (30)	1 (10)
	6	1 (5)	0 (0)	1 (10)
Delta IRANI score [(IRANI Prostatectomy – IRANI Biopsy)/IRANI Prostatectomy]		45% (25–50%)	50% (40–50%)	32.5 (25–50%)	0.7